FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Passmore

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Mark S Henry; Bernadette McGuinness; A Peter Passmore; Stephen Todd; David Craig; Janet A Johnston
The development of effective biomarkers for Alzheimer's disease: a review.
S Todd; B McGuinness; A Peter Passmore
Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven.
Bernadette McGuinness; Robyn Carson; Suzanne Lucia Barrett; David Craig; A Peter Passmore
Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Passmore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark S Henry; Bernadette McGuinness; A Peter Passmore; Stephen Todd; David Craig; Janet A Johnston
The development of effective biomarkers for Alzheimer's disease: a review.
International journal of geriatric psychiatry 2013;28(4):331-40.
2010: S Todd; B McGuinness; A Peter Passmore
Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven.
International journal of clinical practice 2010;64(12):1595-8.
2010: Bernadette McGuinness; Robyn Carson; Suzanne Lucia Barrett; David Craig; A Peter Passmore
Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
Neuroscience letters 2010;483(1):62-6.
2010: Stephen Todd; David Wilson; Bernadette McGuinness; David Craig; A Peter Passmore
Northern Ireland dementia strategy.
International journal of geriatric psychiatry 2010;25(9):902-4.
2010: Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?
Drugs & aging 2010;27(6):435-49.
2010: B McGuinness; S L Barrett; David Craig; J Lawson; A Peter Passmore
Executive functioning in Alzheimer's disease and vascular dementia.
International journal of geriatric psychiatry 2010;25(6):562-8.
2010: Bernadette McGuinness; Suzanne L Barrett; David Craig; John Lawson; A Peter Passmore
Attention deficits in Alzheimer's disease and vascular dementia.
Journal of neurology, neurosurgery, and psychiatry 2010;81(2):157-9.
2009: Enda Kerr; David Craig; Bernadette McGuinness; Kevin B Dynan; Damian Fogarty; Janet A Johnston; A Peter Passmore
Reduced estimated glomerular filtration rate in Alzheimer's disease.
International journal of geriatric psychiatry 2009;24(9):927-32.
2009: Robyn Carson; Amy Jayne McKnight; Stephen Todd; Wei Wei Liu; Shirley Heggarty; David Craig; Bernadette McGuinness; G Brent Irvine; A Peter Passmore; Janet A Johnston
Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.
Neuromolecular medicine 2009;11(4):337-44.
2008: J A Johnston; W W Liu; D T R Coulson; S Todd; S Murphy; S Brennan; CJ Foy; David Craig; G B Irvine; A Peter Passmore
Platelet beta-secretase activity is increased in Alzheimer's disease.
Neurobiology of aging 2008;29(5):661-8.
2008: Robyn Carson; David Craig; Dominic Hart; Stephen Todd; Bernadette McGuinness; Janet A Johnston; Francis Anthony O'Neill; Craig W Ritchie; A Peter Passmore
Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.
Neuromolecular medicine 2008;10(4):377-84.
2008: S Todd; Amy Jayne McKnight; W W Liu; Robyn Carson; Shirley Heggarty; B McGuinness; G Brent Irvine; David Craig; A Peter Passmore; J A Johnston
BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish population.
Neuromolecular medicine 2008;10(4):368-76.
2008: B McGuinness; S Todd; A Peter Passmore; Ross Bullock
Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.
Journal of neurology, neurosurgery, and psychiatry 2008;79(1):4-5.
2007: Yoshio Ito; Azusa Ishii; A Peter Passmore; Stephen P McIlroy
Analysis of alteration of p75NTR processing and signalling by PS2 mutation and gamma-secretase inhibition.
Neurobiology of disease 2007;27(3):258-64.
2007: W W Liu; S Todd; David Craig; A Peter Passmore; D T R Coulson; S Murphy; G B Irvine; J A Johnston
Elevated platelet beta-secretase activity in mild cognitive impairment.
Dementia and geriatric cognitive disorders 2007;24(6):464-8.
2006: David Craig; Dominic J Hart; A Peter Passmore
Genetically increased risk of sleep disruption in Alzheimer's disease.
Sleep 2006;29(8):1003-7.
2005: David Craig; Ajay Mirakhur; Dominic J Hart; Stephen P McIlroy; A Peter Passmore
A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(6):460-8.
2005: A Peter Passmore; Anthony J Bayer; Elisabeth Steinhagen-Thiessen
Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Journal of the neurological sciences 2005;229-230():141-6.
2005: David Craig; Dominic J Hart; Stephen P McIlroy; A Peter Passmore
Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2005;19(2-3):154-7.
2004: A Mirakhur; David Craig; Dominic J Hart; S P McLlroy; A Peter Passmore
Behavioural and psychological syndromes in Alzheimer's disease.
International journal of geriatric psychiatry 2004;19(11):1035-9.
2004: David Craig; Dominic J Hart; Robyn Carson; Stephen P McIlroy; A Peter Passmore
Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Neuroscience letters 2004;368(1):33-6.
2004: David Craig; Dominic J Hart; K McCool; Stephen P McIlroy; A Peter Passmore
Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(9):1327-30.
2004: David Craig; Dominic J Hart; Keira McCool; Stephen P McIlroy; A Peter Passmore
The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.
Annals of neurology 2004;56(1):121-4.
2004: David Craig; Dominic J Hart; Robyn Carson; Stephen P McIlroy; A Peter Passmore
Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.
Neuroscience letters 2004;363(3):199-202.
2004: C E Patterson; A Peter Passmore; Vivienne L S Crawford
A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease.
International journal of clinical practice 2004;58(2):144-8.
2003: Dominic J Hart; David Craig; S A Compton; S Critchlow; B M Kerrigan; Stephen P McIlroy; A Peter Passmore
A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease.
International journal of geriatric psychiatry 2003;18(11):1037-42.
2003: David Craig; A Peter Passmore; Ken J Fullerton; Timothy R O Beringer; David H Gilmore; Vivienne L S Crawford; Patricia M McCaffrey; Anne Montgomery
Factors influencing prescription of CNS medications in different elderly populations.
Pharmacoepidemiology and drug safety 2003;12(5):383-7.
2002: Stephen P McIlroy; Kevin B Dynan; John T Lawson; Chris C Patterson; A Peter Passmore
Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland.
Stroke; a journal of cerebral circulation 2002;33(10):2351-6.
2001: CJ Foy; J Ardill; D Filmore; John T Lawson; A Peter Passmore
Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementia.
QJM : monthly journal of the Association of Physicians 2001;94(11):631-5.
2001: Lawrence T McGrath; BM McGleenon; S Brennan; D McColl; Stephen P McIlroy; A Peter Passmore
Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde.
QJM : monthly journal of the Association of Physicians 2001;94(9):485-90.
2001: S M McCusker; M D Curran; Kevin B Dynan; C D McCullagh; D D Urquhart; DEREK MIDDLETON; Chris C Patterson; Stephen P McIlroy; A Peter Passmore
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
Lancet 2001;357(9254):436-9.
2000: Colm G Hanratty; P McGlinchey; G Dennis Johnston; A Peter Passmore
Differential pharmacokinetics of digoxin in elderly patients.
Drugs & aging 2000;17(5):353-62.
2000: BM McGleenon; A Peter Passmore; DF McAuley; G Dennis Johnston
No evidence of endothelial dysfunction in patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2000;11(4):197-201.
2000: Stephen P McIlroy; MD Vahidassr; D A Savage; F Lloyd; Chris C Patterson; John T Lawson; A Peter Passmore
Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland.
International journal of geriatric psychiatry 2000;15(3):260-6.
2000: Stephen P McIlroy; Vivienne L S Crawford; Kevin B Dynan; BM McGleenon; MD Vahidassr; John T Lawson; A Peter Passmore
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
Journal of medical genetics 2000;37(3):182-5.
1999: BM McGleenon; Kevin B Dynan; A Peter Passmore
Acetylcholinesterase inhibitors in Alzheimer's disease.
British journal of clinical pharmacology 1999;48(4):471-80.
1999: Stephen P McIlroy; Kevin B Dynan; BM McGleenon; John T Lawson; A Peter Passmore
Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease.
Neuroscience letters 1999;273(2):140-1.
1999: Stephen P McIlroy; MD Vahidassr; D A Savage; Chris C Patterson; John T Lawson; A Peter Passmore
Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland.
American journal of medical genetics 1999;88(2):140-4.
1999: CJ Foy; A Peter Passmore; MD Vahidassr; I S Young; John T Lawson
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.
QJM : monthly journal of the Association of Physicians 1999;92(1):39-45.
1998: MD Vahidassr; Kevin B Dynan; CJ Foy; A Peter Passmore
An elderly man with an irritable hip.
Postgraduate medical journal 1998;74(875):547-8.
1997: BM McGleenon; I C Steele; A Peter Passmore
Dysphagia, dysarthria and falls in an elderly man.
Postgraduate medical journal 1997;73(860):321-2.
1997: MD Vahidassr; CJ Foy; T O'Malley; A Peter Passmore
Eye drops and lethargy.
Journal of the Royal Society of Medicine 1997;90(3):155.
1995: A Peter Passmore
Economic aspects of pharmacotherapy for chronic constipation.
PharmacoEconomics 1995;7(1):14-24.
1993: A Peter Passmore; K W Davies; P G Flanagan; C Stoker; M G Scott
A comparison of Agiolax and lactulose in elderly patients with chronic constipation.
Pharmacology 1993;47 Suppl 1():249-52.
1993: A Peter Passmore; K Wilson-Davies; C Stoker; M E Scott
Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination.
BMJ (Clinical research ed.) 1993;307(6907):769-71.